Literature DB >> 9512896

Differential regulation of interleukin 4 and interleukin 13 production by interferon alpha.

A Kaser1, C Molnar, H Tilg.   

Abstract

Interferon alpha (IFN-alpha) has proven its clinical usefulness in a variety of diseases of diverse pathogenesis. In addition to direct antiviral effects, recent evidence suggests that its interaction with the cytokine cascade might contribute to its mechanism of action. This study was undertaken to determine whether IFN-alpha influences the synthesis of interleukin 4 (IL-4) and IL-13, two cytokines which share many biological properties on various cells and tissues and which have a profound role in regulating immunological and inflammatory responses. Peripheral blood mononuclear cells (PBMC) from healthy volunteers were stimulated with Concanavalin A (ConA), phorbol myristate acetate (PMA), anti-CD3/CD28 mAbs, either alone or in various combinations, and incubated with increasing concentrations of IFN-alpha. IL-4 and Il-13 mRNA was determined by Northern hybridizations and IL-4 and IL-13 protein synthesis was evaluated by specific enzyme-linked immunosorbent assay (ELISA). IFN-alpha led to a profound decrease of IL-13 mRNA expression after an incubation period of 5 h with ConA alone or in combination with PMA, whereas it showed no regulatory effect on IL-4 mRNA expression. After an incubation period of 24 h, the decrease in IL-13 mRNA expression after addition of IFN-alpha was even more pronounced. At the protein level, IFN-alpha increased IL-4 synthesis dose dependently regardless of the mode of activation. This increase was most pronounced after stimulation with ConA or anti-CD28/PMA. In contrast, IL-13 synthesis was strongly downregulated by IFN-alpha in a dose-dependent manner irrespective of the activating agent. It is concluded that IL-4 and IL-13, although showing similar biological effects, are differentially regulated by IFN-alpha.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9512896     DOI: 10.1006/cyto.1997.0270

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  14 in total

1.  Illuminating the role of type I IFNs in colitis.

Authors:  Stefan Wirtz; Markus F Neurath
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

2.  Suppression of inflammation in ulcerative colitis by interferon-β-1a is accompanied by inhibition of IL-13 production.

Authors:  Peter J Mannon; Ronald L Hornung; Zhiqiong Yang; Chuli Yi; Catherine Groden; Julia Friend; Michael Yao; Warren Strober; Ivan J Fuss
Journal:  Gut       Date:  2010-10-22       Impact factor: 23.059

3.  Interferon-alpha (IFN-alpha) enhances cytotoxicity in healthy volunteers and chronic hepatitis C infection mainly by the perforin pathway.

Authors:  A Kaser; B Enrich; O Ludwiczek; W Vogel; H Tilg
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

4.  Interferon-α increases monocyte migration via platelet-monocyte interaction in murine intestinal microvessels.

Authors:  M Higashiyama; R Hokari; C Kurihara; T Ueda; M Nakamura; S Komoto; Y Okada; C Watanabe; A Kawaguchi; S Nagao; S Miura
Journal:  Clin Exp Immunol       Date:  2010-08-19       Impact factor: 4.330

5.  Regulation of IL-13 synthesis in human lymphocytes: implications for asthma therapy.

Authors:  Andreas Pahl; Meixia Zhang; Hildegard Kuss; Istvan Szelenyi; Kay Brune
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

6.  Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production.

Authors:  Z Zhu; R J Homer; Z Wang; Q Chen; G P Geba; J Wang; Y Zhang; J A Elias
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

7.  Lessons from type I interferons in ulcerative colitis.

Authors:  Arthur Kaser; Richard S Blumberg
Journal:  Gut       Date:  2011-01-25       Impact factor: 23.059

8.  STAT4-mediated transcriptional repression of the IL5 gene in human memory Th2 cells.

Authors:  Sarah R Gonzales-van Horn; Leonardo D Estrada; Nicolai S C van Oers; J David Farrar
Journal:  Eur J Immunol       Date:  2016-04-08       Impact factor: 5.532

9.  A randomised placebo controlled trial of pegylated interferon alpha in active ulcerative colitis.

Authors:  H Tilg; H Vogelsang; O Ludwiczek; H Lochs; A Kaser; J-F Colombel; H Ulmer; P Rutgeerts; S Krüger; A Cortot; G D'Haens; M Harrer; C Gasche; F Wrba; I Kuhn; W Reinisch
Journal:  Gut       Date:  2003-12       Impact factor: 23.059

Review 10.  The role of type I interferons in intestinal infection, homeostasis, and inflammation.

Authors:  Hyeseon Cho; Brian L Kelsall
Journal:  Immunol Rev       Date:  2014-07       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.